Literature DB >> 12020221

Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia.

Alexander J Chamberlain1, Lin Fritschi, Graham G Giles, John P Dowling, John W Kelly.   

Abstract

OBJECTIVES: To explore the clinical associations of thick melanoma and to compare the clinicopathological variables of nodular and superficial spreading types.
DESIGN: Cross-sectional study of all invasive primary melanomas recorded by the Victorian Cancer Registry for 1998 and those reviewed by the Victorian Melanoma Service between October 1, 1994, and April 31, 1999.
SETTING: Population-based cancer registry and public hospital-based multidisciplinary melanoma clinic. PATIENTS: This study included 1422 patients recorded by the Victorian Cancer Registry and 674 patients who had attended the Victorian Melanoma Service; unclassifiable tumor types were excluded, leaving 1144 and 645 patients, respectively, eligible for analysis. MAIN OUTCOME MEASURES: Melanomas were categorized by thickness into thin (< or =1 mm), intermediate (>1-3 mm), and thick (>3 mm) and compared according to patient age, sex, and tumor type and site. Superficial spreading and nodular types were also compared in this manner. Use of the Victorian Melanoma Service database enabled a more comprehensive analysis of historical and phenotypic characteristics.
RESULTS: Thick melanoma was predominantly nodular, occurring in older men, mostly on the head and neck and associated with fewer nevi. Nodular melanoma was thicker and found mostly on the lower limbs or head and neck; it had a greater association with a history of solar keratoses than did superficial spreading melanoma.
CONCLUSION: Nodular type and older age are the most significant associations of thick melanoma.

Entities:  

Mesh:

Year:  2002        PMID: 12020221     DOI: 10.1001/archderm.138.5.609

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  19 in total

1.  Histological ulceration as a prognostic factor in cutaneous melanoma: a study of 423 cases in Spain.

Authors:  José Antonio Avilés-Izquierdo; Pablo Lázaro-Ochaita
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

Review 2.  No one should die of melanoma: a vision or impossible mission?

Authors:  Iris Zalaudek; Elvira Moscarella; Caterina Longo; Aimilios Lallas; Giuseppe Argenziano; Rainer Hofmann-Wellenhof
Journal:  Melanoma Manag       Date:  2014-09-05

3.  Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.

Authors:  Michael Lattanzi; Yesung Lee; Danny Simpson; Una Moran; Farbod Darvishian; Randie H Kim; Eva Hernando; David Polsky; Doug Hanniford; Richard Shapiro; Russell Berman; Anna C Pavlick; Melissa A Wilson; Tomas Kirchhoff; Jeffrey S Weber; Judy Zhong; Iman Osman
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

Review 4.  Survival is not the only valuable end point in melanoma screening.

Authors:  Clara Curiel-Lewandrowski; Caroline C Kim; Susan M Swetter; Suephy C Chen; Allan C Halpern; John M Kirkwood; Sancy A Leachman; Ashfaq A Marghoob; Michael E Ming; James M Grichnik
Journal:  J Invest Dermatol       Date:  2012-02-16       Impact factor: 8.551

5.  Socioeconomic status and survival in older patients with melanoma.

Authors:  Carlos A Reyes-Ortiz; James S Goodwin; Jean L Freeman; Yong-Fang Kuo
Journal:  J Am Geriatr Soc       Date:  2006-11       Impact factor: 5.562

6.  Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.

Authors:  Clio Dessinioti; Niki Dimou; Alan C Geller; Aravella Stergiopoulou; Serigne Lo; Ulrike Keim; Jeffrey E Gershenwald; Lauren E Haydu; Simone Ribero; Pietro Quaglino; Susana Puig; Josep Malvehy; Lidija Kandolf-Sekulovic; Tatjana Radevic; Roland Kaufmann; Laura Meister; Eduardo Nagore; Victor Traves; Grigorios G Champsas; Mihaela Plaka; Brigitte Dreno; Emilie Varey; David Moreno Ramirez; Reinhard Dummer; Joanna Mangana; Axel Hauschild; Friederike Egberts; Ketty Peris; Laura Del Regno; Ana-Maria Forsea; Sabina A Zurac; Ricardo Vieira; Ana Brinca; Iris Zalaudek; Teresa Deinlein; Eleni Linos; Evangelos Evangelou; John F Thompson; Richard A Scolyer; Claus Garbe; Alexander J Stratigos
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

Review 7.  [Skin diseases in geriatric patients. Epidemiologic data].

Authors:  E Makrantonaki; A I Liakou; R Eckardt; M Zens; E Steinhagen-Thiessen; C C Zouboulis
Journal:  Hautarzt       Date:  2012-12       Impact factor: 0.751

8.  Changes in the presentation of nodular and superficial spreading melanomas over 35 years.

Authors:  Melanie A Warycha; Paul J Christos; Madhu Mazumdar; Farbod Darvishian; Richard L Shapiro; Russell S Berman; Anna C Pavlick; Alfred W Kopf; David Polsky; Iman Osman
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

9.  Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients.

Authors:  Bruce Ng; Jan Zakrzewski; Melanie Warycha; Paul J Christos; Dean F Bajorin; Richard L Shapiro; Russell S Berman; Anna C Pavlick; David Polsky; Madhu Mazumdar; Anthony Montgomery; Leonard Liebes; Peter C Brooks; Iman Osman
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

10.  The anatomic distribution of melanoma and relationships with childhood nevus distribution in Colorado.

Authors:  Ashley L Juhl; Tim E Byers; William A Robinson; Joseph G Morelli; Lori A Crane
Journal:  Melanoma Res       Date:  2009-08       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.